TABLE 4.

Proportional hazards models of time to virologic rebound since suppression

Covariate	Unadjusted			Adjusted
	HR	95% CI	P	HR	95% CI	P
Female	1.66	0.05–2.63	0.03
Recent immigrant	1.36	0.86–2.15	0.19
Immigrant* sex
Nonimmigrant and male	1.00			1.0
Immigrant and male	1.28	0.66–2.49	0.46	1.27	0.65–2.47	0.49
Nonimmigrant and female	1.82	0.91–3.61	0.09	1.93	0.96–3.86	0.06
Immigrant and female	1.74	0.99–3.04	0.05	1.69	1.43–2.68	0.07
Age, per 10 years	0.74	0.56–0.98	0.04
Male who has sex with men	0.69	0.43–1.12	0.13
Injection drug user	0.58	0.14–2.39	0.45
Coinfected with hepatitis C virus	1.35	0.62–2.95	0.45
First HIV-positive test before 2000	1.00
2000–2004	0.70	0.41–1.22	0.21
2005 or later	0.38	0.16–0.93	0.03
Year of cART start	0.99	0.88–1.10	0.81	0.95	0.85–1.06	0.32
NNRTI-based cART	0.82	0.52–1.30	0.40
Viral load at cART start, per log10 copies/mL	0.80	0.62–1.03	0.08
CD4 count at cART start, per 100 cells/mm3	1.28	1.14–1.44	<0.0001	1.31	1.16–1.48	<0.001

cART Combination antiretroviral therapy; NNRTI Non-nucleoside reverse-transcriptase inhibitors